Cat. № NEX-001 · Nexotropin Serum
Nexotropin serum dropper bottle
30 ml · Nexotropin serum

Purity.Verified.

Pharmaceutical-grade Nexotropin skincare — manufactured under EU GMP

Scroll
02 / Reveal

Each batch
verified.

Every Nexotropin bottle ships with a unique batch identifier and a corresponding Certificate of Analysis from an independent lab. Concentration, purity and microbiological safety are tested before any unit leaves the facility.

  • Independent third-party lab
  • COA available per batch
  • CPNP registered (EU 1223/2009)
Nexotropin pharmaceutical box opened, revealing a single dropper bottle in foam tray
03 / Detail

Lab-verified.
GMP-grade.

Manufactured in an EU GMP-certified facility under controlled conditions. Every drop traces back to a single batch lot, with full chain-of-custody documentation available on request.

Concentration
0.5 / 2 / 5 % Nexotropin
Three strengths
Batch
NEX-2426-A07
Traceable per unit
Lab certification
ISO 17025 partner
Independent COA
Macro photograph of a glass pipette with a single drop of pale blue serum forming
05 / Trust

Verify a batch.

Every Nexotropin unit ships with a unique alphanumeric batch identifier engraved into the foam tray and printed on the base. Verify authenticity below.

Sample reference: NEX-2426-A07
Side-view engineering blueprint of the Nexotropin dropper bottle with dimension callouts
Format
30 ml glass
Cap
Anodized Al
Stability
24 mo · ambient
Origin
EU GMP
Certifications & registrations
GMPGood Manufacturing Practice
ISO 9001Quality Management
CPNPCosmetic Product Notification (EU)
EFSAEFSA-compliant ingredients
ISO 17025Independent lab
06 / Commitment

Manufactured to pharmaceutical standards.Tested in independent labs.
Traceable per unit.
Shipped with discretion.

Nexotropin is formulated and produced in an EU GMP-certified facility under cosmetic regulation 1223/2009. Each batch is released only after independent third-party testing for purity, potency and microbiological safety.

Flat-lay of a dropper bottle next to a Certificate of Analysis document